MolNFT v1 · #136677 · RNA
RNA duplex with 2-meimpg analogue bound-2 binding sites
5V0J · RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG)…: “RNA duplex with 2-meimpg analogue bound-2 binding sites”. X-ray diffraction, 2 ligands (8OS, MG), 1 pocket (best druggability 0.48). MolNFT v1 #136677 on GenesisL1: 3D structure, binding…
- PDB
- 5V0J
- Type
- RNA
- Length
- 28 nucleotides
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3')
- Ligands
- 8OS, MG
- Pockets
- 1 · best druggability 0.48
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') | rna | 14 | — | — |
Ligands and binding sites
- 8OS · 5'-O-[(S)-hydroxy(4-methyl-1H-imidazol-5-yl) phosphoryl]guanosine · ligand · 4 copies · chains A, B
- MG · Magnesium ion · metal
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 316 | 0.48 | 0.73 | 20 | empty |
Interfaces
1 interface between chains.
- A–B · 538 Ų buried · 43 hydrogen bonds · nucleic-nucleic
Modifications
Observed in the structure: 8 modified (nucleotide modification).
Compared structures
- 5V0J · RNA duplex with 2-MeImpG analogue bound-2 binding sites · the same entry in another collection · chain B against B, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 5V0J · PDBe 5V0J
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.